Purchase Order 75D30122P13776
Award Date 4/29/22
Potential Completion Date 4/28/23
Potential Value $182K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $11,400 by the Centers for Disease Control and Prevention (CDC) Pittsburgh on January 27, 2021. The contract, with an ultimate completion date of February 15, 2021, was issued without a set-aside designation, reflecting Illumina's specialized position as a technology provider for sequencing...
- This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
- This is a purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents. The $137,112.53 firm fixed price contract is for the delivery of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems and related consumables and services to support genomic research and diagnostics for various federal agencies, including the National...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $51,750.47, is to provide the CDC's Pittsburgh facility with Illumina's advanced DNA and RNA sequencing instruments, reagents, consumables, maintenance services, and bioinformatics software. The contract is not associated with a set-aside...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for $63,884.20. The award is not associated with a set-aside program. Illumina has a history of providing sequencing systems and related consumables to support genomic research and diagnostics work across various federal agencies including the National Institutes of Health, USDA, and...